UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

UnitedHealth Group Incorporated (NYSE ... was mutually agreed upon by Mr. Witty and the company. Despite recent leadership changes, InvestingPro data shows UnitedHealth maintains strong ...

Humana has endorsed similar policies as Congress seeks spending reductions to offset the cost of President Donald Trump's tax cuts.

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Despite recent leadership changes, InvestingPro data shows UnitedHealth maintains strong fundamentals with a P/E ratio of 12.5 and has consistently raised dividends for 15 consecutive years.

Pfizer offers a dividend yield over 7%, but it's payout probably won't rise very fast in the decade ahead. Investors seeking ...

An internal document reveals how UnitedHealth Group's leadership prepared to downplay complaints about its business practices ...

The nation’s two largest Medicare Advantage (MA) insurers say they support reforming the federal program to rein in certain ...

UnitedHealth said that Hemsley intends to stay on as CEO for at least three years. Its governance committee reviews and ...

UNH's CEO pledges reform after rare earnings miss as rising Medicare Advantage costs squeeze margins and spook investors.